Literature DB >> 17972798

[Lupus nephritis in children and adolescents (clinical-morphologic correlation)].

R Bogdanović, M Mikuska, A Cvorić, V Nikolić, M Sindjić, M Ognjanović, M Abinun.   

Abstract

Clinical and laboratory features in 27 children and adolescents (24 females, 3 males) with lupus nephritis were analysed and correlated with pathohistologic findings obtained by renal biopsy. The mean age at the onset of the disease was 12.1 +/- 1.9 (range 0.1-7.0) years. In the 30% of patients nephritis was one of the presenting features of the disease. The most frequent signs of the lupus nephritis at the time of biopsy were proteinuria (9 pts), proteinuria and haematuria (9 pts), and nephrotic syndrome (8 pts), while 7 patients showed decreased glomerular filtration rate (GFR), and hypertension was present in five. Distribution of patients according to the WHO morphologic classification of Lupus nephritis was as follows: 6 pts showed class Ib, 6 class II, 2 class III and 13 class IV. More severe renal dysfunction, manifested by nephrotic syndrome, proteinuria with haematuria, decreased GFR and hypertension was significantly associated with proliferative lupus nephritis (combined WHO classes III and IV). Nephrotic syndrome, haematuria and decreased serum C3 with significant probability predicted proliferative lupus nephritis, while decreased GFR was of borderline predictive value.

Entities:  

Mesh:

Year:  1994        PMID: 17972798

Source DB:  PubMed          Journal:  Srp Arh Celok Lek        ISSN: 0370-8179            Impact factor:   0.207


  2 in total

1.  Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt.

Authors:  Ashraf Bakr
Journal:  Pediatr Nephrol       Date:  2005-06-07       Impact factor: 3.714

2.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.